Safety of intravenous tranexamic acid in patients undergoing major orthopaedic surgery: A meta-analysis of randomised controlled trials

Blood Transfusion

Volumn 16, Issue 1, 2018, Pages 36-43

  Franchini, Massimo ^a,b   Mengoli, Carlo ^a   Marietta, Marco ^c   Marano, Giuseppe ^a   Vaglio, Stefania ^a,d   Pupella, Simonetta ^a   Mannucci, Pier Mannuccio ^e   Liumbruno, Giancarlo M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Orthopaedic surgery; Safety; Thromboembolic events.; Tranexamic acid

Indexed keywords

TRANEXAMIC ACID;

DRUG SAFETY; HUMAN; INCIDENCE; MAJOR SURGERY; META ANALYSIS; ORTHOPEDIC SURGERY; PATIENT SAFETY; PERCEPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; OPERATIVE BLOOD LOSS; RISK FACTOR;

ADMINISTRATION, INTRAVENOUS; BLOOD LOSS, SURGICAL; FEMALE; HUMANS; MALE; ORTHOPEDIC PROCEDURES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TRANEXAMIC ACID; VENOUS THROMBOEMBOLISM;

EID: 85041203614     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2017.0219-17     Document Type: Review

References (105)

1. Mannucci PM. Hemostatic drugs. N Engl J Med 1998; 339: 245-53.
2. Franchini M, Mannucci PM. Adjunct agents for bleeding. Curr Opin Hematol 2014; 21: 503-8.
3. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007; 356: 2301-11.
4. Schulman S. Pharmacologic tools to reduce bleeding in surgery. Hematology Am Soc Hematol Educ Program 2012; 2012: 517-21.
5. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
6. Ker K, Roberts I, Shakur H, Coats TJ. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2015; 5: CD004896.
7. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389: 2105-16.
8. Gerstein NS, Brierley JK, Windsor J, et al. Antifibrinolytic agents in cardiac and noncardiac surgery: a comprehensive overview and update. J Cardiothorac Vasc Anesth 2017; S1053-0770 (17) 30079-4.
9. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; 3: CD001886.
10. Jiang X, Ma XL, Ma JX. Efficiency and safety of intravenous tranexamic acid in simultaneous bilateral total knee arthroplasty: a systematic review and meta-analysis. Orthop Surg 2016; 8: 285-93.
11. Moskal JT, Capps SG. Meta-analysis of intravenous tranexamic acid in primary total hip arthroplasty. Orthopedics 2016; 39: e883-92.
12. Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics 2016; 39: 119-30.
13. He P, Zhang Z, Li Y, et al. Efficacy and safety of tranexamic acid in bilateral total knee replacement: a meta-analysis and systematic review. Med Sci Monit 2015; 21: 3634-42.
14. Wei Z, Liu M. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases. Transfus Med 2015; 25: 151-62.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12.
16. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996; 78: 434-40.
17. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997; 84: 839-44.
18. Jansen AJ, Andreica S, Claeys M, et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999; 83: 596-601.
19. Ekback G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000; 81: 1124-30.
20. Engel JM, Hohaus T, Ruwoldt R, et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 2001; 92: 775-80.
21. Ellis MH, Fredman B, Zohar E, et al. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth 2001; 13: 509-13.
22. Tanaka N, Sakahashi H, Sato E, et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 2001; 83: 702-5.
23. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001; 72: 442-8.
24. Veien M, Sørensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand 2002; 46: 1206-11.
25. Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003; 90: 596-9.
26. Husted H, Blond L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 2003; 74: 665-9.
27. Zohar E, Ellis M, Ifrach N, et al. The postoperative bloodsparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 2004; 99: 1679-83.
28. Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty 2004; 19: 488-92.
29. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty: prospective randomized study in 40 cases. Int Orthop 2004; 28: 69-73.
30. Lemay E, Guay J, Côté C, Roy A. Tranexamic acid reduces the need for allogeneic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004; 51: 31-7.
31. Niskanen RO, Korkala OL. Tranexamic acid reduces blood loss in cemented hip arthroplasty. A randomized, double blind study of 39 patients with osteoarthritis. Acta Orthop 2005; 76: 829-32.
32. Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop 2005; 76: 314-9.
33. Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 2006; 13: 106-10.
34. Camarasa MA, Olle G, Serra-Prat M, et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 2006; 96: 576-82.
35. Molloy DO, Archbold HA, Ogonda L, et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br 2007; 89: 306-9.
36. Sadeghi M, Mehr-Aein A. Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Med Iran 2007; 45: 437-42.
37. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007; 107: 397-401.
38. Alvarez JC, Santiveri FX, Ramos I, et al. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008; 48: 519-25.
39. Kakar P, Gupta N, Govil P, et al. Efficacy and safety of tranexamic acid in control of bleeding following TKR: a randomized clinical trial. Ind J Anaesthesia 2009; 53: 667-71.
40. Zufferey PJ, Miquet M, Quenet S, et al.; for the investigators of tranexamic acid in hip fracture surgery (THIF) study. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 2010; 104: 23-30.
41. Kazemi SM, Mosaffa F, Eajazi A, et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics 2010; 33: 17.
42. MacGillivray RG, Tarabichi SB, Hawari MF, et al. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty 2011; 26: 24-8.
43. Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 2011; 469: 2874-80.
44. Malhotra R, Kumar V, Garg B. The use of tranexamic acid to reduce blood loss in primary cementless total hip arthroplasty. Eur J Orthop Surg Traumatol 2012; 21: 101-4.
45. McConnell JS, Shewale S, Munro NA, et al. Reducing blood loss in primary knee arthroplasty: a prospective randomized controlled trial of tranexamic acid and fibrin spray. Knee 2012; 19: 295-8.
46. Chareancholvanich K, Siriwattanasakul P, Narkbunnam R, Pornrattanamaneewong C. Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial. BMC Musculoskelet Disord 2012; 13: 124.
47. Maniar RN, Kumar G, Singhi T, et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012; 470: 2605-12.
48. Lin PC, Hsu CH, Huang CC, et al. The blood-saving effect of tranexamic acid in minimally invasive total knee replacement. Is an additional pre-operative injection effective? J Bone Joint Surg Br 2012; 94-B: 932-6.
49. Raviraj A, Anand A, Chakravarthy M, et al. Tranexamic acid reduces blood loss in simultaneous bilateral total knee arthroplasty: a randomized control trial. Eur J Orthop Surg Traumatol 2012; 22: 381-6.
50. Imai N, Dohmae Y, Suda K, et al. Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 2012; 27: 1838-43.
51. Gautam VK, Sambandam B, Singh S, et al. The role of tranexamic acid in reducing blood loss in total knee replacement. J Clin Orthop Trauma 2013; 4: 36-9.
52. Seo JG, Moon YW, Park SH, et al. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013; 21: 1869-74.
53. Aguilera X, Martinez-Zapata MJ, Bosch A, et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am 2013; 95: 2001-7.
54. Vijai BS, Bedi V, Mitra S, Das B. Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi J Anaesth 2013; 7: 29-32.
55. Lee YC, Park SJ, Kim JS, Cho CH. Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement. J Clin Anesth 2013; 25: 393-8.
56. Kim TK, Chang CB, Kang YG, et al. Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2014; 22: 1870-8.
57. Huang Z, Ma J, Shen B, et al. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 2014; 29: 2342-6.
58. Patel JN, Spanyer JM, Smith LS, et al. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 2014; 29: 1528-31.
59. Soni A, Saini R, Gulati A, et al. Comparison between intravenous and intra-articular regimens of tranexamic acid I reducing blood loss during total knee arthroplasty. J Arthroplasty 2014; 29: 1525-7.
60. Sarzaeem MM, Razi M, Kazemian G, et al. Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J Arthroplasty 2014; 29: 1521-4.
61. Pachauri A, Acharya KK, Tiwari AK. The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty. Am J Ther 2014; 21: 366-70.
62. Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, et al. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement. J Bone Joint Surg Am 2014; 96: 1937-44.
63. Oremus K, Sostaric S, Trkulja V, Haspl M. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion 2014; 54: 31-41.
64. Wei W, Wei B. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty 2014; 29: 2113-6.
65. Emara WM, Moez KK, Elkhouly AH. Topical versus intravenous tranxamic acid as a blood conservation intervention for reduction ofmpost-operative bleeding in hemiarthoplasty. Anesth Essays Res 2014; 8: 48-53.
66. Shinde A, Sobti A, Maniar S, et al. Tranexamic acid reduces blood loss and need of blood transfusion in total knee arthroplasty: a prospective, randomized, double-blind study in Indian population. Asian J Transfusion Sci 2015; 9: 168-72.
67. Lin SY, Chen CH, Fu YC, et al. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplasty 2015; 30: 776-80.
68. Karaaslan F, Karaoglu S, Mermerkaya MU, et al. Reducing blood loss in simultaneous bilateral total knee arthroplasty: combined intravenous-intra-articular tranexamic acid administration. A prospective randomized controlled trial. Knee 2015; 22: 131-5.
69. Aguilera X, Martinez-Zapata MJ, Hinarejos P, et al. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg 2015; 135: 1017-25.
70. Shen PF, Hou WH, Chen JB, et al. Effectiveness and safety of tranexamic acid for total knee arthroplasty: a prospective randomized controlled trial. Med Sci Monit 2015; 21: 576-81.
71. Hsu CH, Lin PC, Kuo FC, Wang JW. A regime of two intravenous injections of tranexamic acid reduces blood loss in minimally invasive total hip arthroplasty. A prospective randomized doubleblind study. Bone Joint J 2015; 97-B: 905-10.
72. Mohib Y, Rashid RH, Ali M, et al. Does tranexamic acid reduce blood transfusion following surgery for intertrochanteric fracture? A randomized controlled trial. J Pak Med Assoc 2015; 65 (Suppl 3): S17-20.
73. Nielsen CS, Jans O, Orsnes T, et al. Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty. A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 2016; 98: 835-41.
74. Drosos GI, Ververidis A, Valkanis C, et al. A randomized comparative study of topical versus intravenous tranexamic acid administration in enhanced recovery after surgery (ERAS) total knee replacement. J Orthop 2016; 13: 127-31.
75. Chen X, Cao X, Yang C, et al. Effectiveness and safety of fixed-dose tranexamic acid in simultaneous bilateral total knee arthroplasty: a randomized double-blind controlled trial. J Arthroplasty 2016; 31: 2471-5.
76. Xie J, Ma J, Yao H, et al. Multiple boluses of intravenous tranexamic acid to reduce hiden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplasty 2016; 31: 2458-64.
77. Tzatzairis T, Drosos GI, Kotsios SE, et al. Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study. J Arthroplasty 2016; 31: 2465-70.
78. Jain NP, Nisthane PP, Shah NA. Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplasty 2016; 1: 542-7.
79. Xie J, Yue C, Kang P, Pei F. Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomized clinical trial. Hip Int 2016; 26: 36-42.
80. Wu YG, Zeng Y, Yang TM, et al. The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial. J Arthroplasty 2016; 31: 2548-53.
81. Tengberg PT, Foss NB, Palm H, et al. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip. Results of a randomized controlled trial. Bone Joint J 2016; 98-B: 747-53.
82. Yi Z, Bin S, Jing Y, et al. Tranexamic acid administration in primary total hip arthroplasty. A randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 2016; 98: 983-91.
83. Zhang Y, Zhang L, Ma X, et al. What is the optimal approach for tranexamic acid application in patients with unilateral total hip arthroplasty? Orthopade 2016; 45: 616-21.
84. Maniar R, Singhi T, Patil A, et al. Optimizing efficacy of tranexamic acid in bilateral knee arthroplasty-a prospective randomized controlled study. Knee 2017; 24: 100-6.
85. Lee SY, Chong S, Balasubramanian D, et al. What is the ideal route of administration of tranexamic acid in TKA? A randomized controlled trial. Clin Orthop Relat Res 2017; 475: 1987-96.
86. Lei Y, Xie J, Xu B, et al. The safety and efficacy of multipledose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial. Int Orthop 2017; 41: 2053-9.
87. Wang JW, Chen B, Lin PC, et al. The efficacy of the combined use of rivaroxaban an tranexamic acid on blood conservation in minimally invasive total knee arthroplasty a double-blind randomized controlled trial. J Arthroplasty 2017; 32: 801-6.
88. Vara AD, Koueiter DM, Pinkas DE, et al. Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial. J Shoulder Elbow Surg 2017; 8: 1383-9.
89. Higgins JPT, Green S (editors). 16.9.5 Validity of methods of meta-analysis for rare events. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (2011). Available at: http://handbook.cochrane.org/chapter-16/16-9-5-validity-of-methods-of-meta-analysis-for-rare-events.htm. Accessed on 15/09/2017.
90. Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Statist Med 2007; 26: 53-77.
91. Tian L, Cai T, Pfeffer MA, et al. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2x2 tables with all available data but without artificial continuity correction. Biostatistics 2009; 10: 275-81.
92. Kurtz SM, Ong KL, Lau E, Bozic KJ. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am 2014; 96: 624-30.
93. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60.
94. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
95. Liumbruno GM, Vaglio S, Biancofiore G, et al. Transfusion thresholds and beyond. Blood Transfus 2016; 14: 123-5.
96. Franchini M, Marano G, Mengoli C, et al. Red blood cell transfusion policy: a critical literature review. Blood Transfus 2017; 15: 307-17.
97. Guerra R, Velati C, Liumbruno GM, Grazzini G. Patient blood management in Italy. Blood Transfus 2016; 14: 1-2.
98. Vaglio S, Prisco D, Biancofiore G, et al. Recommendations for the implementation of a patient blood management programme. Application to elective major orthopaedic surgery in adults. Blood Transfus 2016; 14: 23-65.
99. Franchini M, Muñoz M. Towards the implementation of patient blood management across Europe. Blood Transfus 2017; 15: 292-3.
100. Vaglio S, Gentili S, Marano G, et al. The Italian regulatory guidelines for the implementation of patient blood management. Blood Transfus 2017; 15: 325-8.
101. Muñoz M, Gómez-Ramírez S, Liumbruno GM. Perioperative anaemia management in major orthopaedic surgery: the need to find a pathway. Blood Transfus 2017; 15: 289-91.
102. Melvin JS, Stryker LS, Sierra RJ. Tranexamic acid in hip and knee arthroplasty. J Am Acad Orthop Surg 2015; 23: 732-40.
103. Poole D. Coagulopathy and transfusion strategies in trauma. Overwhelmed by literature, supported by weak evidence. Blood Transfus 2016; 14: 3-7.
104. Wu Q, Zhang HA, Liu SL, et al. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur J Orthop Surg Traumatol 2015; 25: 525-41.
105. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184.